Aspire Biopharma Inc.

NASDAQ: ASBP · Real-Time Price · USD
0.46
-0.13 (-22.03%)
At close: Aug 19, 2025, 12:04 PM

Aspire Biopharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-1.21M -358.59K -596.49K
Interest Income
548.68K 5.81M 4.32M
Pretax Income
-12.54M -358.59K -596.49K
Net Income
-12.54M -359.07K -597.12K
Selling & General & Admin
1.07M 286.54K 421.18K
Research & Development
144.36K 72.05K 175.32K
Other Expenses
1.88M n/a n/a
Operating Expenses
3.09M 358.59K 596.49K
Interest Expense
891.62K 8.97K n/a
Selling & Marketing Expenses
126.09K 39.64K 45.48K
Cost & Expenses
3.09M 358.59K 596.49K
Income Tax Expense
1.01K 481.00 626.00
Shares Outstanding (Basic)
8.24M 45.94M 45.94M
Shares Outstanding (Diluted)
8.24M 45.94M 45.94M
EPS (Basic)
-1.52 -0.01 -0.01
EPS (Diluted)
-1.52 -0.01 -0.01
EBITDA
-11.65M -358.59K -596.49K
EBIT
-11.65M -358.59K -596.49K
Depreciation & Amortization
n/a n/a n/a